Status:
COMPLETED
Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this trial is to investigate the relative bioavailability of a BI 144807 tablet formulation compared to the oral solution formulation after single dose administration (intermediate and ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Healthy male subjects
- Exclusion criteria:
- \- Any relevant deviation from healthy condition
Exclusion
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01897597
Start Date
July 1 2013
End Date
September 1 2013
Last Update
September 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1313.9.1 Boehringer Ingelheim Investigational Site
Biberach, Germany